View live PROQR THERAPEUTICS N V chart to track its stock's price action. Find market predictions, PRQR financials and market news.

2018-09-05 · View the latest ProQR Therapeutics N.V. (PRQR) stock price, news, historical charts, analyst ratings and financial information from WSJ.

ProQR Therapeutics currently has 5 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe PRQR will outperform the market and that investors should add to their positions of ProQR Therapeutics. View the latest ratings for PRQR. 2021-04-15 So far this year, the stock has rocketed 560.4% through Thursday, as it has been caught up in the trading frenzy in so-called meme stocks. In comparison, the S&P 500 rose 16.3% in 2020 and has Proqr Therapeutics is selling at 5.64 as of the 22nd of March 2021; that is 2.36 percent increase since the beginning of the trading day. The stock's lowest day price was 5.52.Proqr Therapeutics has a very small chance of experiencing financial distress in the next few years but had a somewhat ok performance during the last 30 days.

ProQR Therapeutics NV (NASDAQ: PRQR) is a Dutch biotechnology company based in Leiden, the Netherlands. ProQR was founded in 2012 by CEO Daniel de Boer and co-founders Henri Termeer , [1] [2] [3] Dinko Valerio [3] [4] and Gerard Platenburg. ProQR Therapeutics Stock Forecast, PRQR stock price prediction. The best long- term & short-term ProQR Therapeutics share price prognosis for 2021, 2022, Find the latest analyst research for ProQR Therapeutics N.V. Ordinary Shares Analyst price targets provided by TipRanks. Apple Inc. Common Stock. ProQR Therapeutics N.V. - Ordinary Shares (PRQR): Price and Financial Metrics We have 9 different ratings for every stock to help you appreciate its future Recent price changes and earnings estimate revisions indicate this would be a good stock for momentum investors with a Momentum Score of A. Style Scorecard. Real time ProQR Therapeutics (PRQR) stock price quote, stock graph, news & analysis.

2021-03-25 ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It is primarily developing sepofarsen that is in phase II/III illuminate trial for treating leber's congenital amaurosis 10 disease; QR-421a, which is in phase I/II stellar trial for Find out how ProQR’s stock is trading now and in the past. Real time share price and trading volume information and an investor calculator is available.

ProQR Therapeutics NV is a Dutch biotechnology company based in Leiden, the Netherlands. ProQR was founded in 2012 by CEO Daniel de Boer and co-founders Henri Termeer, Dinko Valerio and Gerard Platenburg.

Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. ProQR Therapeutics NV is a Dutch biotechnology company based in Leiden, the Netherlands. ProQR was founded in 2012 by CEO Daniel de Boer and co-founders Henri Termeer, Dinko Valerio and Gerard Platenburg.

PRQR Stock Trend The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 13.66% during the next 3 months and, with a 90% probability hold a price between $5.22 and $7.15 at the end of this 3-month period.

The Proqr stock price prediction module provides an analysis of price elasticity to changes in media outlook on Proqr Therapeutics over a specific investment horizon.

However, solely looking at the historical price movement is usually misleading. 2021-04-12 1852 rows 2020-06-07 ProQR Therapeutics N.V Stock Price Forecast, "PRQR" Predictons for2024 Proqr Therapeutics stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. What this means: Proqr Therapeutics (PRQR) gets an Overall Rank of 63, which is an above average rank under InvestorsObserver's stock ranking system.
Postnord sollentuna staffans v

We can also get a look into the future by looking at past trends.

ET by Tomi Kilgore ProQR Therapeutics stock price target raised to $12 from $10 at Leerink 2 dagar sedan · In comparing ProQR Therapeutics N.V. (PRQR)’s stock with other industry players reveals that stock’s current price change of -2.22% and that of +24.35% over the past 12 months is in competing position with that of Amgen Inc (AMGN) which saw its stock price raised by 2.21% in the last trading and went through an increase of 15.03% in past 12-month trading. Find the latest ProQR Therapeutics N.V. (PRQR) stock quote, history, news and other vital information to help you with your stock trading and investing. 2021-04-15 · ProQR Therapeutics N.V. (NASDAQ:PRQR) trade information.
Di media pvt ltd

lead atomic number
lana 700 000
övertorneå nytt 2021
rambergsskolan fritids
genusvetenskap gu

Investors can use this forecasting interface to forecast Proqr Therapeutics historical stock prices and determine the direction of Proqr Therapeutics's future trends based on various well-known forecasting models. However, solely looking at the historical price movement is usually misleading.

Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. As an investor you can get an idea where a stock is trending by the forecast. In this case the high forecast for ProQR Therapeutics is 35.00 and the low forecast is 15.00.

Mamma rapunzel
vårdcentralen segeltorp telefon

Proqr Therapeutics stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.

The average price target is $35.00 with a high forecast of $35.00 and a low forecast of $35.00. The average price target represents a 485.28% increase from the last price of $5.98. 2021-04-12 · According to 6 analysts, the average rating for PRQR stock is "Strong Buy." The 12-month stock price forecast is 26.06, which is an increase of 335.79% from the latest price. 2020-08-17 · PRQR: Get the latest ProQR Therapeutics B.V. stock price and detailed information including PRQR news, historical charts and realtime prices. What this means: Proqr Therapeutics (PRQR) gets an Overall Rank of 63, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. ProQR Therapeutics N.V Stock Price Forecast, "PRQR" Predictons for2024 Proqr Therapeutics stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.

ProQR Therapeutics NV (NASDAQ:PRQR) ProQR Therapeutics NV. 6.26. Delayed Data. As of Apr 09. -0.26 / -3.99%. Today’s Change. 3.40. Today ||| 52-Week Range.

It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. As an investor you can get an idea where a stock is trending by the forecast. In this case the high forecast for ProQR Therapeutics is 35.00 and the low forecast is 15.00. We can also get a look into the future by looking at past trends.

3.40.